Marksans Pharma Overview
- Founded
-
1992

- Status
-
Public
- Employees
-
890

- Stock Symbol
-
MARKSANS

- Investments
-
6
- Share Price
-
$0.76
- (As of Wednesday Closing)
Marksans Pharma General Information
Description
Marksans Pharma Ltd is a pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical formulations. It manufactures analgesics, expectorants, anti-diabetic, cardiovascular, central nervous system, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. The company also offers Contract Research and Manufacturing Services (CRAMS) to pharmaceutical companies. It has a global market presence with the majority of the revenue generated from North America, Europe, and the United Kingdom.
Contact Information
- 11th Floor, Grandeur
- Veera Desai Extension Road, Oshiwara, Andheri West
- Mumbai, Maharashtra 400053
- India
Marksans Pharma Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.76 | $0.79 | $0.50 - $0.86 | $339M | 447M | 2.68M | $0.06 |
Marksans Pharma Financials Summary
In Thousands, USD |
TTM 30-Sep-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
---|---|---|---|---|
EV | 202,114 | 209,340 | 262,268 | 80,741 |
Revenue | 215,716 | 198,654 | 183,921 | 158,948 |
EBITDA | 42,145 | 39,151 | 45,783 | 26,559 |
Net Income | 25,904 | 25,073 | 32,062 | 16,995 |
Total Assets | 204,735 | 216,291 | 167,310 | 119,686 |
Total Debt | 12,320 | 14,609 | 4,643 | 3,931 |
Marksans Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Marksans Pharma Comparisons
Industry
Financing
Details
Marksans Pharma Competitors (17)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Novartis India | Corporation | Mumbai, India | 00 | 00.000 | 00000000000 | 00.000 |
00000000 00000000 | Corporation | Noida, India | 0000 | 00000 | 00000000000 | 00000 |
00000 | Corporation | Mumbai, India | 00000 | 00000000 | ||
000000 | Formerly PE-Backed | Bengaluru, India | 00000 | 000.00 | 00000000 | 000.00 |
000000000000000 00 | Corporation | Lagos, Nigeria | 00 |
Marksans Pharma Patents
Marksans Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220079894-A1 | Stable pharmaceutical compositions | Pending | 11-Sep-2020 | 0000000000 |
Marksans Pharma Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Mark Saldanha | Founder Promoter, Chairman, Managing Director & Chief Executive Officer | ||
Jitendra Sharma | Chief Financial Officer |
Marksans Pharma Signals
Marksans Pharma Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Marksans Pharma Acquisitions (6)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000 (00 | 11-Oct-2022 | 0000000000 | Pharmaceuticals | 0000 0000 | |
000000 000000 | 06-Jun-2022 | 0000000000 | 00.000 | Media and Information Services (B2B) | 0000 0000 |
0000-000 0000 | 30-Jun-2015 | 0000000000 | 0000 | Pharmaceuticals | 0000 0000 |
000000000 | 28-Aug-2008 | 0000000000 | 000.00 | Distributors/Wholesale | 0000 0000 |
Hale Group | 18-Jan-2008 | Merger/Acquisition | Holding Companies | 0000 0000 |
Marksans Pharma Subsidiaries (4)
Company Name | Industry | Location | Founded |
---|---|---|---|
Nova Pharmaceuticals Australasia | Drug Discovery | Australia | 2003 |
000000000 | Distributors/Wholesale | Widnes, United Kingdom | 0000 |
0000-000 0000 | Pharmaceuticals | Farmingdale, NY | 0000 |
000000 0000000000 | Media and Information Services (B2B) | Dubai, United Arab Emirates |
Marksans Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Pharmaceuticals
Subindustry
Rank
Percentile

Marksans Pharma Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000 00000 | 18-Jan-2008 | 000000000000000000 | Completed |
|